Media coverage
4
Media coverage
Title Merck : Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection Media name/outlet 4 Traders Country United States Date 11/13/16 Persons Eric J Lawitz Title Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates... Media name/outlet Freshnews.com Country United States Date 11/13/16 Persons Eric J Lawitz Title Merck & Co Inc: Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection (Businesswire) Media name/outlet Avanza Bank AB Country Sweden Date 11/13/16 Persons Eric J Lawitz Title Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained ... Media name/outlet EIN News Country United States Date 11/13/16 Persons Eric J Lawitz